Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7342 p349
26 March 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Shipman case pharmacist cleared with no case to answer

Ghislaine Brant, the pharmacist who dispensed prescriptions for diamorphine that was subsequently used by Harold Shipman to kill many of his patients, has been cleared of any wrongdoing by the Royal Pharmaceutical Society’s Statutory Committee (see p374).

The committee ruled earlier this week that Mrs Brant had no case to answer.

The Society’s Council had alleged that she had dispensed excessive doses of diamorphine, failed to keep appropriate stocks of diamorphine, failed to scrutinise prescriptions adequately, failed to exercise sufficient control over what was supplied and failed to exercise the professional objectivity and judgement expected of a reasonably competent pharmacist.

Committee chairman Lord Fraser of Carmyllie said that the Society had been right to bring the case because a serious professional issue had to be explored, but the committee had heard no evidence that Mrs Brant dispensed quantities of diamorphine that she ought to have known were excessive. He said that she should be praised, not pilloried. “Had it not been for her meticulous record-keeping retained long after the law required it of her, much of what the police uncovered about Dr Shipman would have been lost for ever.”

The National Pharmaceutical Association welcomed the ruling. NPA chief executive, John D’Arcy, said: “This ruling makes it clear that … pharmacists will be judged against what a reasonably competent pharmacist would do rather than against a counsel of perfection armed with the considerable benefit of hindsight.”

A spokeswoman for the Society said that all decisions made by the Statutory Committee are sent to the Council for Healthcare Regulatory Excellence, which then has 28 days to decide whether it will refer the case to the High Court.

Back to Top


©The Pharmaceutical Journal